BIRC5 and neoplasm: Furthermore, the substantial tumor regression observed with N-containing regimens was further supported by our observation of great inhibition in the levels of the anti-apoptotic marker Survivin and marginal increase in the levels of the pro-apoptotic marker cleaved PARP (c-PARP), compared to T and P, either alone or in combination (Fig. 3a).